Shivan M. Sivakumar
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Breaking the RAS Barrier in Pancreatic Cancer.
Journal: The New England journal of medicine
Published: July 22, 2026
Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer: a UK multicentre cohort study.
Journal: Annals of the Royal College of Surgeons of England
Published: April 09, 2026
Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review.
Journal: Journal of clinical medicine
Published: March 17, 2026
Real-world evidence for atezolizumab with bevacizumab for unresectable hepatocellular carcinoma: a multicentre UK Midlands cohort.
Journal: BMC cancer
Published: February 27, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2026
Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative intent: single centre cohort study.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: December 24, 2025
Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients.
Journal: NPJ precision oncology
Published: September 18, 2025
Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway.
Journal: Cancer medicine
Published: September 01, 2025
UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme.
Journal: Cancers
Published: July 14, 2025
Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma.
Journal: Journal of clinical and translational hepatology
Published: June 23, 2025
In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment.
Journal: Cell reports
Published: November 11, 2024
Last Updated: 09/26/2026